The Serbian Economist reports – German pharmaceutical company Phoenix Pharma has announced plans to invest around 14 million euros in the construction of a state-of-the-art distribution centre in Leskovac, Serbia. The project involves the creation of a 1.5-hectare facility as part of the development of the Leskovac Green Zone, which is positioned as a key logistics and business hub for the region.
Strategic importance of the project
The new centre will serve not only the local market, but also the entire territory of Serbia, ensuring efficient distribution of pharmaceutical products, including medicines, food supplements, cosmetics and medical devices. About 120 jobs are expected to be created, which will be a significant contribution to the development of the regional economy.
The Mayor of Leskovac, Goran Cvetanovic, emphasised the importance of this investment project for the local economy, noting that it contributes to the creation of new jobs and strengthens the position of the “green zone” as a key business territory.
Phoenix Pharma is a subsidiary of Phoenix Pharmahandel AG & Co KG, one of the largest pharmaceutical distributors in Europe. The company is headquartered in Mannheim, Germany. Phoenix Pharmahandel operates in more than 27 countries in Europe, providing distribution services for pharmaceuticals, medical devices and related products.
In the financial year 2023, the group had a turnover of more than €25 billion and employs more than 39,000 people. The company is actively investing in the expansion of its logistics network, including the construction of new distribution centres and the implementation of state-of-the-art technologies to optimise supply chains.
Phoenix Pharmahandel has an extensive geographical presence, including such countries as Germany, France, Italy, Spain, UK, Netherlands, Belgium, Austria, Switzerland, Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Serbia and others. The company serves more than 150,000 customers, including pharmacies, hospitals and other healthcare facilities, ensuring timely and reliable delivery of pharmaceutical products.